BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20797646)

  • 1. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barré syndrome after exposure to influenza].
    Hartung HP; Keller-Stanislawski B; Hughes RA; Lehmann HC
    Nervenarzt; 2012 Jun; 83(6):714-30. PubMed ID: 22528062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study.
    Grave C; Boucheron P; Rudant J; Mikaeloff Y; Tubert-Bitter P; Escolano S; Hocine MN; Coste J; Weill A
    Neurology; 2020 May; 94(20):e2168-e2179. PubMed ID: 32098853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
    Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
    Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
    Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
    Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.
    Cortese A; Baldanti F; Tavazzi E; Carnevale L; Minoli L; Lozza A; Marchioni E
    J Neurol Sci; 2012 Jan; 312(1-2):173-6. PubMed ID: 22000408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
    Greene SK; Rett M; Weintraub ES; Li L; Yin R; Amato AA; Ho DT; Sheikh SI; Fireman BH; Daley MF; Belongia EA; Jacobsen SJ; Baxter R; Lieu TA; Kulldorff M; Vellozzi C; Lee GM
    Am J Epidemiol; 2012 Jun; 175(11):1100-9. PubMed ID: 22582210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Iqbal S; Li R; Gargiullo P; Vellozzi C
    Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.